Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu

Detalhes bibliográficos
Autor(a) principal: Castro, Júlia T.
Data de Publicação: 2021
Outros Autores: Caldas, Gabriela de Assis Burle, Gonçalves, Ana Paula de Faria, Doro, Daniel, Cardoso, Kimberly Freitas, Teixeira, Santuza Maria Ribeiro, Machado, Alexandre de Magalhães Vieira, Gazzinelli, Ricardo Tostes
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/46734
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_9d9efc0d56329e0c873898ffaff90aa3
oai_identifier_str oai:www.arca.fiocruz.br:icict/46734
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Castro, Júlia T.Caldas, Gabriela de Assis BurleGonçalves, Ana Paula de FariaDoro, DanielCardoso, Kimberly FreitasTeixeira, Santuza Maria RibeiroMachado, Alexandre de Magalhães VieiraGazzinelli, Ricardo Tostes2021-04-16T14:29:42Z2021-04-16T14:29:42Z2021CASTRO, Júlia T. et al. Development of influenza virus expressing the antigenic portion of SARS-CoV-2 S protein as a vaccine to prevent Covid19 and flu. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 115.https://www.arca.fiocruz.br/handle/icict/4673410.35259/isi.2021_46734Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Universidade Federal de Minas Gerais. CT-Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT-Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosSARS-CoV-2Vírus influenzaVacinaISICoronavirusSARS-CoV-2Influenza virusVaccineInternational Symposium on ImmunobiologicalsBetacoronavirusOrthomyxoviridaeVacinasDevelopment of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and fluinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83108https://www.arca.fiocruz.br/bitstream/icict/46734/1/license.txt155f7d692661a91111cc666068bcb611MD51ORIGINALVAC_21.pdfVAC_21.pdfapplication/pdf206643https://www.arca.fiocruz.br/bitstream/icict/46734/2/VAC_21.pdf78b430d31620c7e23f862ee4413b8bebMD52TEXTVAC_21.pdf.txtVAC_21.pdf.txtExtracted texttext/plain3491https://www.arca.fiocruz.br/bitstream/icict/46734/3/VAC_21.pdf.txte5b87849407d38bf957b92deae85e998MD53icict/467342023-04-26 16:56:53.221oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:56:53Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
title Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
spellingShingle Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
Castro, Júlia T.
SARS-CoV-2
Vírus influenza
Vacina
ISI
Coronavirus
SARS-CoV-2
Influenza virus
Vaccine
International Symposium on Immunobiologicals
Betacoronavirus
Orthomyxoviridae
Vacinas
title_short Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
title_full Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
title_fullStr Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
title_full_unstemmed Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
title_sort Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
author Castro, Júlia T.
author_facet Castro, Júlia T.
Caldas, Gabriela de Assis Burle
Gonçalves, Ana Paula de Faria
Doro, Daniel
Cardoso, Kimberly Freitas
Teixeira, Santuza Maria Ribeiro
Machado, Alexandre de Magalhães Vieira
Gazzinelli, Ricardo Tostes
author_role author
author2 Caldas, Gabriela de Assis Burle
Gonçalves, Ana Paula de Faria
Doro, Daniel
Cardoso, Kimberly Freitas
Teixeira, Santuza Maria Ribeiro
Machado, Alexandre de Magalhães Vieira
Gazzinelli, Ricardo Tostes
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castro, Júlia T.
Caldas, Gabriela de Assis Burle
Gonçalves, Ana Paula de Faria
Doro, Daniel
Cardoso, Kimberly Freitas
Teixeira, Santuza Maria Ribeiro
Machado, Alexandre de Magalhães Vieira
Gazzinelli, Ricardo Tostes
dc.subject.other.pt_BR.fl_str_mv SARS-CoV-2
Vírus influenza
Vacina
ISI
Coronavirus
topic SARS-CoV-2
Vírus influenza
Vacina
ISI
Coronavirus
SARS-CoV-2
Influenza virus
Vaccine
International Symposium on Immunobiologicals
Betacoronavirus
Orthomyxoviridae
Vacinas
dc.subject.en.pt_BR.fl_str_mv SARS-CoV-2
Influenza virus
Vaccine
International Symposium on Immunobiologicals
dc.subject.decs.pt_BR.fl_str_mv Betacoronavirus
Orthomyxoviridae
Vacinas
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-04-16T14:29:42Z
dc.date.available.fl_str_mv 2021-04-16T14:29:42Z
dc.date.issued.fl_str_mv 2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv CASTRO, Júlia T. et al. Development of influenza virus expressing the antigenic portion of SARS-CoV-2 S protein as a vaccine to prevent Covid19 and flu. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 115.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/46734
dc.identifier.doi.none.fl_str_mv 10.35259/isi.2021_46734
identifier_str_mv CASTRO, Júlia T. et al. Development of influenza virus expressing the antigenic portion of SARS-CoV-2 S protein as a vaccine to prevent Covid19 and flu. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 115.
10.35259/isi.2021_46734
url https://www.arca.fiocruz.br/handle/icict/46734
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/46734/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/46734/2/VAC_21.pdf
https://www.arca.fiocruz.br/bitstream/icict/46734/3/VAC_21.pdf.txt
bitstream.checksum.fl_str_mv 155f7d692661a91111cc666068bcb611
78b430d31620c7e23f862ee4413b8beb
e5b87849407d38bf957b92deae85e998
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009044055523328